Arena is a biopharmaceutical company focused on discovering and developing novel, small molecule drugs. We are currently directing our activities and resources primarily on:
Display all Answers
Arena’s fiscal year ends on December 31.
You can sign up for email alerts to receive notification of announcements and upcoming events here.
At this time Arena does not offer a direct stock purchase plan.
Oct 11, 2016
Arena Pharmaceuticals Announces Acceptance of Late Breaking Etrasimod Abstract at the United European Gastroenterology Week (UEGW) Meeting
Oct 3, 2016
Eisai Inc. and Arena Pharmaceuticals Announce Availability of Once-Daily BELVIQ XR® (lorcaserin HCl) Extended-Release Tablets
There are no upcoming events available at this time.
You are now leaving arenapharm.com and being directed to a site not maintained by Arena. Arena is not responsible for content or privacy policies on other sites.